Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Distribution of Molecular Speeds

Distribution of Molecular Speeds

The motion of molecules in a gas is random in magnitude and direction for individual molecules, but a gas of many molecules has a predictable distribution of molecular speeds. This predictable distribution of molecular speeds is known as the Maxwell-Boltzmann distribution. The distribution of molecular speeds in liquids is comparable to that of gases but not identical and can help to understand the phenomenon of the boiling and vapor pressure of a liquid. Consider that a molecule requires a...

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...

Bioequivalence Data: Statistical Interpretation

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pharmacological therapies for neglected tropical diseases: a systematic review and evidence gap mapping.

Revista da Sociedade Brasileira de Medicina Tropical·2026

Same author

Mapping the Technological and Pharmacological Landscape of Casearia sylvestris: An Evidence-Based Prospection for Wound Healing and Pain Management.

Chemistry & biodiversity·2026

Same author

Barriers to and facilitators of healthcare access among people experiencing homelessness: a systematic scoping review.

International journal for equity in health·2026

Same author

Key performance indicators for hospital clinical pharmacy services: results of a global Delphi study.

International journal of clinical pharmacy·2026

Same author

Informing a medical subject heading (MeSH) request: The 'Prescribing cascades' case study.

Research in social & administrative pharmacy : RSAP·2026

Same author

Criteria used in clinical practice guidelines for the management of pharmaceutical service.

Ciencia & saude coletiva·2026

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

Publication speed in pharmacy practice journals: A comparative analysis.

Antonio M Mendes¹, Fernanda S Tonin¹, Felipe F Mainka¹

¹Pharmaceutical Sciences Postgraduate Program, Federal University of Paraná, Curitiba, Brazil.

|June 29, 2021

Summary

The publication duration for pharmacy practice journals is comparable to other biomedical journals, with similar acceptance, lead, and indexing lags. This study analyzed publication timelines to address concerns about the scholarly publishing process duration.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on: October 24, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

Published on: October 17, 2013

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on: October 24, 2019

Area of Science:

Bibliometrics
Scholarly Communication
Pharmacy Practice Research

Background:

The scholarly publishing system relies on peer review, but the extended publication duration is a significant concern for authors and funding bodies.
Evaluating publication timelines is crucial for understanding and potentially improving the efficiency of scientific dissemination.

Purpose of the Study:

To compare the duration of the publication process in pharmacy practice journals with other biomedical journals indexed in PubMed.
To quantify and compare key stages of the editorial process: acceptance lag, lead lag, and indexing lag.

Main Methods:

A study group of 26,256 articles from 33 pharmacy practice journals (2009-2018) indexed in PubMed was compiled.
A comparison group of 23,803 articles was randomly selected from other biomedical journals indexed in PubMed for the same period.
The duration of the editorial process was calculated by analyzing acceptance lag, lead lag, and indexing lag using metadata from PubMed.

Main Results:

Pharmacy practice journals had an acceptance lag of 105 days (IQR 57-173) compared to 97 days (IQR 56-155) in the comparison group, with a negligible effect size.
Lead lag was 13 days (IQR 6-35) for pharmacy practice journals versus 23 days (IQR 9-45) for the comparison group, indicating a small effect.
Indexing lag was similar, with 5 days (IQR 2-46) for pharmacy practice journals and 4 days (IQR 2-12) for the comparison group, also a small effect.

Conclusions:

The overall publication process duration for pharmacy practice journals is similar to that of a general random sample of articles across all disciplines.
These findings suggest that pharmacy practice journals are comparable to other biomedical fields in terms of publication efficiency.